Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Prepaid Assets (2019 - 2025)

Legend Biotech filings provide 7 years of Prepaid Assets readings, the most recent being $253.4 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 93.44% to $253.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $253.4 million, a 93.44% increase, with the full-year FY2025 number at $253.4 million, up 93.44% from a year prior.
  • Prepaid Assets hit $253.4 million in Q4 2025 for Legend Biotech, up from $219.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $253.4 million in Q4 2025 to a low of $10425.0 in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $67.9 million (2023), compared with a mean of $92.6 million.
  • Biggest five-year swings in Prepaid Assets: tumbled 66.67% in 2021 and later soared 183132.61% in 2022.
  • Legend Biotech's Prepaid Assets stood at $13.9 million in 2021, then surged by 345.82% to $61.8 million in 2022, then rose by 12.14% to $69.3 million in 2023, then skyrocketed by 89.17% to $131.0 million in 2024, then soared by 93.44% to $253.4 million in 2025.
  • The last three reported values for Prepaid Assets were $253.4 million (Q4 2025), $219.0 million (Q3 2025), and $219.1 million (Q2 2025) per Business Quant data.